主权项 |
1. A compound represented by structural Formula (I) or pharmaceutically acceptable salts thereof:wherein:
R1 is hydrogen or —COR3; R2 is (C6-C16)aryl, (C3-C10)heteroaryl, (C1-C6)alkyl, (C1-C6)cycloalkyl, (C2-C6)alkenyl, or C≡CH; R2 is optionally substituted with 1-5 substituents independently selected from (C1-C6)alkyl, halogen, amino, cyano, —COOH, halo(C1-C6)alkyl, hydroxy(C0-C6)alkyl, (C6-C10)aryl, (C3-C10)heteroaryl, halo(C6-C10)aryl, hydroxy(C6-C10)aryl, (C1-C6)alkoxy, halo(C1-C6)alkoxy, (C6-C16)aryloxy, (C3-C8)cycloalkyl, halo(C6-C10)aryl(C1-C6)alkoxy, (C1-C6)alkoxy(C6-C10)aryl(C1-C6)alkoxy, nitro, (C0-C6)alkyl(C6-C10)aryl(C0-C6)alkoxy, (C5-C10)heterocycle, —OCHF2, —OCF3, —SCF3, —OBn, cyano(C1-C6)alkylene, (C1-C6)alkoxyamino, (C6-C10)aryl(C2-C6)alkenyl, (C2-C6)alkenyl(C1-C6)alkoxy, (C2-C6)alkenyl, (C2-C6)alkenyl(C6-C10)aryl, —N((C0-C6)alkyl)((C1-C6)alkyl), —N((C1-C6)alkyleneOH)((C1-C6)alkyleneOH), —N((C0-C6)alkyl)((C1-C6)alkyleneOH), —N((C1-C6)alkyleneOCO(C1-C6)alkyl)((alkyleneOCO(C1-C6)alkyl), —NCO(C1-C6)alkyl, —NPh2, —OPh(halogen)0-3, —OPhO(C1-C6)alkyl, —OPhO(C1-C6)alkyl, —OCO(C1-C6)alkyl, —OCO(C1-C6)alkoxy, —O(C1-C6)alkyl(C6-C10)aryl, —O(C2-C6)alkenyl, —O(C2-C6)alkyleneN(CH3)2, (C0-C6)alkylCOO(C1-C6)alkyl, —B(OH)2 or —S(C1-C6)alkyl; and wherein any of the substituents selected from (C1-C6)alkyl, (C1-C6)alkoxy, (C6-C10)aryl, (C6-C16)aryloxy or (C5-C10)heteroaryl is further optionally substituted with 1-4 substituents selected from halogen, (C1-C6)alkyl, halo(C1-C6)alkyl, amino, nitro, cyano, hydroxy(C0-C6)alkyl, (C1-C6)alkoxy, —COO(C0-C6)alkyl, or —CHO; and R3 is (C1-C15)alkyl, (C2-C15)alkenyl, (C2-C15)alkynyl, (C6-C10)aryl or (C5-C10)heteroaryl, wherein R3 is optionally substituted with 1-4 substituents independently selected from halogen, amino, cyano or hydroxyl. |